894.20
+8.40
+(0.95%)
At close: January 21 at 5:32:33 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 19 | 11 | 24 | 24 |
Avg. Estimate | 2.27B | 2.28B | 8.76B | 9.46B |
Low Estimate | 2.21B | 2.21B | 8.7B | 9.04B |
High Estimate | 2.31B | 2.33B | 8.8B | 9.67B |
Year Ago Sales | 2.11B | 2.13B | 8.19B | 8.76B |
Sales Growth (year/est) | 7.79% | 7.17% | 7.00% | 7.97% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
EQIX.VI | -- | -- | -- | -- |
S&P 500 | 9.34% | 11.29% | 14.06% | 13.55% |
Upgrades & Downgrades
Maintains | RBC Capital: Outperform to Outperform | 12/11/2024 |
Maintains | Wells Fargo: Overweight to Overweight | 12/10/2024 |
Maintains | Truist Securities: Buy to Buy | 11/29/2024 |
Maintains | Stifel: Buy to Buy | 11/20/2024 |
Maintains | Barclays: Equal-Weight to Equal-Weight | 11/18/2024 |
Maintains | Scotiabank: Sector Outperform to Sector Outperform | 10/31/2024 |